A Phase I Trial of Vorinostat in Combination With Bevacizumab & Irinotecan in Recurrent Glioblastoma

This study is ongoing, but not recruiting participants.

Study NCT00762255 Information provided by H. Lee Moffitt Cancer Center and Research Institute

First Received: September 29, 2008 Last Updated: September 20, 2011 History of Changes

No Study Results Posted on ClinicalTrials.gov for this Study

Study Status:	This study is ongoing, but not recruiting participants.
Estimated Study Completion Date:	January 2013
Estimated Primary Completion Date:	January 2013 (Final data collection date for primary outcome measure)